INTRABEAM
Device
Carl Zeiss Meditec, Inc.
Total Payments
$787,593
Transactions
339
Doctors
97
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $22,243 | 41 | 16 |
| 2023 | $19,521 | 24 | 13 |
| 2022 | $7,827 | 4 | 3 |
| 2021 | $17,486 | 27 | 14 |
| 2020 | $19,271 | 31 | 18 |
| 2019 | $37,127 | 46 | 22 |
| 2018 | $222,930 | 103 | 37 |
| 2017 | $441,189 | 63 | 32 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $542,918 | 2 | 68.9% |
| Travel and Lodging | $105,113 | 142 | 13.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $57,700 | 35 | 7.3% |
| Consulting Fee | $44,279 | 27 | 5.6% |
| Education | $21,750 | 54 | 2.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,400 | 13 | 1.2% |
| Food and Beverage | $6,433 | 66 | 0.8% |
Payments by Type
Research
$542,918
2 transactions
General
$244,675
337 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Folling Breast-conserving Surgery. | Carl Zeiss Meditec, Inc. | $394,740 | 0 |
| Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Folling Breast-conserving Surgery. | Carl Zeiss Meditec, Inc. | $148,178 | 0 |
Top Doctors Receiving Payments for INTRABEAM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $542,918 | 2 |
| , M.D | Surgery | Los Angeles, CA | $45,003 | 39 |
| , M.D | Surgery | Barrington, IL | $17,372 | 17 |
| , MD | Specialist | Emeryville, CA | $13,197 | 11 |
| , M.D | Radiation Oncology | Chicago, IL | $13,029 | 18 |
| , M.D | Surgery | San Francisco, CA | $8,892 | 5 |
| , MD | Radiation Oncology | Cleveland, OH | $8,643 | 7 |
| , MD, PHD | Neurological Surgery | Morgantown, WV | $8,618 | 7 |
| , M.D | Surgical Oncology | New York, NY | $8,093 | 8 |
| , MD | Surgery | Gainesville, FL | $4,934 | 7 |
| , D.O | Student in an Organized Health Care Education/Training Program | New York, NY | $3,964 | 7 |
| , MD | Neurological Surgery | Phoenix, AZ | $3,500 | 1 |
| , M.D | Radiation Oncology | Zion, IL | $3,420 | 7 |
| , MD | Surgery | Brooklyn, NY | $3,379 | 5 |
| , M.D | Surgical Oncology | Miami, FL | $3,158 | 2 |
| , MD | Radiation Oncology | Tampa, FL | $3,143 | 3 |
| , M.D | Radiation Oncology | Rio Piedras, PR | $2,822 | 3 |
| , M.D | Surgery | East Lansing, MI | $2,800 | 2 |
| , MD | Surgery | Albuquerque, NM | $2,748 | 4 |
| , M.D | Radiation Oncology | New York, NY | $2,563 | 3 |
| , MD | Surgery | Union, SC | $2,561 | 6 |
| , MD | Radiation Oncology | Greenville, NC | $2,556 | 3 |
| Sukamal Saha | — | Flint, MI | $2,395 | 3 |
| , MD | Surgery | Des Moines, IA | $2,373 | 4 |
| , MD | Surgery | Anchorage, AK | $2,233 | 4 |
Ad
Manufacturing Companies
- Carl Zeiss Meditec, Inc. $729,734
- Carl Zeiss Meditec USA, Inc. $57,576
- Carl Zeiss Meditec AG $282.65
Product Information
- Type Device
- Total Payments $787,593
- Total Doctors 97
- Transactions 339
About INTRABEAM
INTRABEAM is a device associated with $787,593 in payments to 97 healthcare providers, recorded across 339 transactions in the CMS Open Payments database. The primary manufacturer is Carl Zeiss Meditec, Inc..
Payment data is available from 2017 to 2024. In 2024, $22,243 was paid across 41 transactions to 16 doctors.
The most common payment nature for INTRABEAM is "Unspecified" ($542,918, 68.9% of total).
INTRABEAM is associated with 2 research studies, including "Targeted Intraoperative Radiotherapy United States (TARGIT-US) Phase IV Registry Trial: A Registry Trial of Targeted Intraoperative Radiation Therapy Folling Breast-conserving Surgery." ($394,740).